TCL Archive Conference Bill Includes Funding For DOD For Breast, Prostate, Ovarian Cancer October 4, 1996
TCL Archive Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge? October 7, 2005
TCL Archive NCI Advisors Discuss Cap On Center Core Grants While Broder Complains Cap Is ‘Anti-Intellectual’ May 17, 1991
TCL Archive Chemical Industry Sues NTP Over Listing PDC As Carcinogen; Environmental Groups Join Defense June 23, 1989
TCL Archive DC E Bard Approves Health Plan Study Recompetition, New Acrylonitrile Contract March 16, 1984
